| Literature DB >> 26708362 |
Munther M Queisi1, Mike Zein1, Neerav Lamba1, Halea Meese1, Charles Stephen Foster2.
Abstract
Mucous membrane pemphigoid is a systemic disorder that primarily affects mucous membranes. When localized to the conjunctiva, it is known as ocular cicatricial pemphigoid, a potentially blinding disease. Ocular cicatricial pemphigoid is an indication for systemic immunosuppressive treatment to achieve adequate remission. Immunosuppressive agents are selected with a "stepladder" approach, commencing with medications having the fewest side effects. We provide an update of the literature on immunomodulatory agents since 2011 as additional treatment modalities have been explored in the last 4 years.Entities:
Keywords: alkylating agents; biologic agents; chemotherapy; immunomodulatory therapy; mucus membrane pemphigoid; ocular cicatricial pemphigoid
Mesh:
Substances:
Year: 2015 PMID: 26708362 DOI: 10.1016/j.survophthal.2015.12.007
Source DB: PubMed Journal: Surv Ophthalmol ISSN: 0039-6257 Impact factor: 6.048